Ivan Spasojevic Selected Research

manganese (III) meso- tetrakis(N- ethylpyridinium- 2- yl)porphyrin

1/2021	H2O2-Driven Anticancer Activity of Mn Porphyrins and the Underlying Molecular Pathways.
11/2018	Radiation-Mediated Tumor Growth Inhibition Is Significantly Enhanced with Redox-Active Compounds That Cycle with Ascorbate.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ivan Spasojevic Research Topics

Disease

50	Neoplasms (Cancer) 01/2022 - 09/2002
13	Glioma (Gliomas) 01/2021 - 02/2011
7	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 07/2007
7	Hyperthermia 01/2020 - 07/2006
6	Brain Neoplasms (Brain Tumor) 01/2021 - 09/2011
5	Glioblastoma (Glioblastoma Multiforme) 06/2020 - 01/2015
5	Colonic Neoplasms (Colon Cancer) 01/2020 - 06/2011
4	Wounds and Injuries (Trauma) 01/2021 - 04/2011
4	Head and Neck Neoplasms (Head and Neck Cancer) 01/2021 - 11/2015
4	Hypoxia (Hypoxemia) 01/2019 - 10/2009
4	Radiation Injuries (Radiation Sickness) 03/2018 - 06/2010
4	Breast Neoplasms (Breast Cancer) 01/2016 - 10/2009
3	Carcinogenesis 10/2021 - 05/2012
2	Obesity 06/2021 - 09/2012
2	Ischemic Stroke 01/2021 - 01/2020
2	Stroke (Strokes) 01/2021 - 01/2020
2	Hypotension (Low Blood Pressure) 01/2020 - 05/2013
2	Colorectal Neoplasms (Colorectal Cancer) 11/2018 - 06/2011
2	Fibrosis (Cirrhosis) 03/2018 - 01/2017
2	Virus Diseases (Viral Diseases) 08/2017 - 09/2015
2	Non-alcoholic Fatty Liver Disease 08/2017 - 09/2015
2	Ependymoma 07/2017 - 01/2017
2	Diffuse Intrinsic Pontine Glioma 07/2017 - 01/2015
2	Neuroblastoma 07/2017 - 01/2017
2	Medulloblastoma 07/2017 - 01/2017
2	Neutropenia 01/2017 - 07/2006
2	Inflammation (Inflammations) 01/2016 - 01/2012
2	Metabolic Diseases (Metabolic Disease) 09/2015 - 06/2010
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 08/2012 - 08/2008
2	Spinal Cord Compression 08/2004 - 05/2004
1	Acute Kidney Injury (Acute Renal Failure) 01/2022
1	Disease Progression 01/2022
1	Neoplasm Metastasis (Metastasis) 01/2022

Drug/Important Bio-Agent (IBA)

17	PorphyrinsIBA 01/2021 - 10/2005
15	Pharmaceutical PreparationsIBA 01/2022 - 10/2005
9	AntioxidantsIBA 01/2016 - 08/2004
8	ManganeseIBA 01/2021 - 08/2004
7	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2009
7	EnzymesIBA 10/2019 - 01/2009
7	Superoxide DismutaseIBA 12/2018 - 10/2005
7	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2018 - 07/2006
6	alpha-hydroxyglutarateIBA 10/2019 - 02/2011
5	Peptides (Polypeptides)IBA 01/2022 - 08/2015
5	F2-Isoprostanes (F2 Isoprostanes)IBA 06/2021 - 01/2012
5	Niclosamide FDA Link 01/2020 - 06/2011
5	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2018 - 02/2011
4	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 01/2016
4	Biological ProductsIBA 01/2020 - 06/2011
4	Oxidoreductases (Dehydrogenase)IBA 10/2019 - 01/2009
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019 - 10/2012
4	CateninsIBA 11/2018 - 06/2011
4	NADP (NADPH)IBA 08/2014 - 02/2011
3	Androgen Receptors (Androgen Receptor)IBA 01/2022 - 10/2016
3	epidermal growth factor receptor VIIIIBA 06/2020 - 01/2019
3	hydroxide ionIBA 01/2020 - 07/2007
3	isocitric acid (isocitrate)IBA 10/2019 - 02/2011
3	MetalsIBA 12/2018 - 11/2014
3	Glutathione (Reduced Glutathione)IBA 11/2018 - 01/2009
3	Mn(III) meso- tetrakis(N- n- butoxyethylpyridinium- 2- yl)porphyrinIBA 01/2016 - 01/2015
3	Liposomes (Liposome)IBA 01/2010 - 07/2006
2	Adenosine (Adenocard)FDA LinkGeneric 10/2021 - 10/2012
2	manganese (III) meso- tetrakis(N- ethylpyridinium- 2- yl)porphyrinIBA 01/2021 - 11/2018
2	Therapeutic UsesIBA 01/2021 - 01/2013
2	ErbB Receptors (EGF Receptor)IBA 06/2020 - 01/2020
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2020 - 08/2015
2	Albumin-Bound Paclitaxel FDA Link 01/2020 - 08/2015
2	DNA (Deoxyribonucleic Acid)IBA 10/2019 - 10/2009
2	Free RadicalsIBA 03/2018 - 06/2010
2	GTP-Binding Proteins (G-Protein)IBA 01/2018 - 02/2011
2	AnthelminticsIBA 08/2017 - 09/2015
2	perifosineIBA 07/2017 - 01/2017
2	dipinacoline glutamateIBA 07/2017 - 01/2017
2	CathepsinsIBA 01/2017 - 11/2015
2	mitoquinoneIBA 01/2016 - 05/2012
2	Biomarkers (Surrogate Marker)IBA 01/2012 - 06/2010
2	AEOL 10150IBA 09/2011 - 08/2004
2	Peroxynitrous Acid (Peroxynitrite)IBA 04/2011 - 10/2009
2	liposomal doxorubicin (Doxil)FDA Link 06/2010 - 11/2006
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2010 - 10/2009
2	fludarabineIBA 08/2008 - 12/2007
2	CytokinesIBA 10/2005 - 09/2002
1	MacrolidesIBA 01/2022
1	FluorocarbonsIBA 01/2022
1	Sirolimus (Rapamycin)FDA Link 01/2022
1	gluconic acid (gluconate)FDA LinkGeneric 01/2022
1	Disulfiram (Antabuse)FDA Link 01/2022
1	cupric chloride (copper(II) chloride)FDA Link 01/2022
1	CopperIBA 01/2022
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2022
1	PlatinumIBA 01/2022
1	Adenosine Triphosphate (ATP)IBA 10/2021
1	Adenosine Monophosphate (AMP)IBA 10/2021
1	Adenosine Diphosphate (ADP)IBA 10/2021
1	beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA 10/2021
1	CD39 antigenIBA 10/2021
1	Interleukin-6 (Interleukin 6)IBA 06/2021

Therapy/Procedure

21	Therapeutics 01/2022 - 08/2004
8	Radiotherapy 01/2021 - 09/2002
6	Drug Therapy (Chemotherapy) 01/2020 - 10/2009
2	Castration 01/2022 - 10/2016